Study Explores Iodine's Role in Obesity, Diabetes, Metabolism

Bern, 21 Mar (ONA) --- A recent study published in Frontiers in Nutrition delved into the metabolic implications of iodine consumption, shedding light on its intricate mechanisms.

Iodine, crucial for thyroid hormone production, has been linked to metabolic disorders like diabetes, obesity, dyslipidemia, and hypertension.

Despite this, the precise pathways remain unclear. Iodine's diverse effects, including immunomodulation and antioxidant properties, influence energy metabolism through thyroxine and tri-iodothyronine regulation.

Metabolic syndrome (MetS), comprising various health risks, is globally prevalent and associated with oxidative stress, inflammation, and dietary factors.

Nutritional iodine status may contribute to MetS incidence.

Recommended iodine intake ranges from 150 to 299 μg/day, with certain studies suggesting benefits in cancer prevention.

Research indicates complex relationships between iodine levels and MetS prevalence, with different effects observed across genders and populations.

Understanding these dynamics could inform iodine's role in promoting metabolic health and refining dietary guidelines.

Iodine's multifaceted actions on oxidative stress, inflammation, and metabolic pathways underscore its potential as a therapeutic target for metabolic disorders.

Overall, the review findings indicate that iodine's role in regulating metabolism, impacting obesity, lipid profiles, and glucose metabolism. Its antioxidant and immunomodulatory effects are crucial.

However, both shortages and excesses can harm thyroid health. Maintaining optimal iodine levels is key, urging for refined nutrition standards based on evidence-backed research.

---Ends/Thuraiya/AG